Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
-
Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
-
Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Histone Deacetylase 6 - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This report offers a detailed analysis...
-
Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "TCR Therapy - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.The T-cell receptor (TCR) therapy landscape has been...
-
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "PD-1 x VEGF and PD-L1 x VEGF Bispecific Antibodies: A Business, Pipeline And Competitor Analysis From An Industry Perspective" report has been added...
-
Dublin, Dec. 23, 2024 (GLOBE NEWSWIRE) -- The "Gynecological Cancer Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
-
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer...
-
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Combination Antibody Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
-
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic...
-
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Immune Checkpoint Inhibitors Market size reached USD 47.4 billion in 2023 and is projected to register a CAGR of 16.7% from 2024 to 2032...